At myTomorrows, we believe everyone should be able to access the treatment options which are open to them. We strive to make it easier for physicians and their patients with unmet medical needs to find, get information about, and access pre-approval medicines whenever possible.
We believe that by making the process of accessing pre-approval medicines more transparent, we’ll be able to transform the lives of people all over the world.
To contact us, please visit https://www.mytomorrows.com/en/get-in-contact.
We believe that by making the process of accessing pre-approval medicines more transparent, we’ll be able to transform the lives of people all over the world.
To contact us, please visit https://www.mytomorrows.com/en/get-in-contact.
Location: Netherlands, North Holland, Amsterdam
Employees: 51-200
Total raised: $18.39M
Founded date: 2012
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors |
| 10.01.2017 | - | $10.59M | Octopus Ve... |
| 07.11.2014 | - | $5.6M | - |
| 19.02.2014 | - | $2.2M | - |
Mentions in press and media 16
| Date | Title | Description |
| 27.08.2024 | myTomorrows partners with Pancreatic Cancer Europe to streamline clinical trials | myTomorrows, a global health technology company connecting patients with possible treatment options, twill partner with with Pancreatic Cancer Europe, a multi-stakeholder platform that brings together experts from all over Europe with a com... |
| 22.03.2022 | How a Platform-based, Patient-Centric, Triaging Solution Can Accelerate Clinical Trial Recruitment, Upcoming Webinar Hosted by Xtalks | Patients in need of treatment options increasingly expect a frictionless business-to-consumer experience. TORONTO (PRWEB) March 22, 2022 Clinical trial recruitment is transforming in response to change in the world. Seismic events such as t... |
| 10.01.2017 | Amsterdam-based myTomorrows raises €10 million to improve access to drugs in development | Amsterdam-based myTomorrows, a platform to help patients and doctors access drugs in development, has closed a €10 million funding round. The round was led by EQT Ventures and Octopus Ventures, with participation from existing investors Bal... |
| 09.01.2017 | Amsterdam-based myTomorrows raises €10 million to improve access to drugs in development for physicians and patients | Founded to facilitate access to drugs in development for physicians and their patients, myTomorrows today announced a €10 million growth funding round, co-led by EQT Ventures and Octopus Ventures. Existing investors Balderton Capital and So... |
| 09.01.2017 | MyTomorrows raises $10.5 million to connect doctors and patients with early-stage drug programs | MyTomorrows, an online platform that connects physicians and patents to early-stage drug research and development programs, has raised €10 million ($10.5 million) in a funding round co-led by Octopus Ventures and EQT Ventures, with particip... |
| 09.01.2017 | Drug Access Platform myTomorrows Raises €10M in Funding | myTomorrows, an Amsterdam, The Netherlands-based provider of a drug access platform, raised €10m in growth funding. The round was co-led by EQT Ventures and Octopus Ventures, with participation from existing investors Balderton Capital and ... |
| 09.01.2017 | Term Sheet — Monday, January 9 | 10X EXIT, CYBER, FASHION Good morning, readers. Some quick notes to kick off your week. It’s a healthy exit for Trello’s investors – sources tell Term Sheet the deal will deliver a multiple of around 10x. The company had raised $10.3 millio... |
| 09.01.2017 | MyTomorrows raises further €10M to help access drugs in development | MyTomorrows, the Netherlands-headquartered startup that has built a platform to help physicians and patients access drugs that are still in development, has raised €10 million in further funding. Leading the round is EQT Ventures, and Octop... |
| 09.01.2017 | MyTomorrows raises $10.5 million to connect doctors and patients with early-stage drug programs | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more. MyTomorrows, an online platform that connects physicians and patents to early-stage drug research and development programs, has raised ... |
| 10.11.2014 | MyTomorrows Raises €4.5M in Financing | MyTomorrows, an Amsterdam, The Netherlands-based online healthcare platform providing early access to drug innovations, raised €4.5m in its first institutional financing. The round was led by Balderton Capital and Sofinnova Partners. The co... |
Show more